awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47140652-10DE42B2-498D-4EB0-A7AF-279BC24BB1BD
Q47140652-10DE42B2-498D-4EB0-A7AF-279BC24BB1BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47140652-10DE42B2-498D-4EB0-A7AF-279BC24BB1BD
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/CIP2A axis.
P2860
Q47140652-10DE42B2-498D-4EB0-A7AF-279BC24BB1BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47140652-10DE42B2-498D-4EB0-A7AF-279BC24BB1BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e854c240dd4377b07a5761c8c49718df4982612
P2860
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.